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Newrapid,sensitive,andaccuratekineticspectrophotometricmethodsweredeveloped,fortheﬁrsttime,todetermineomeprazole
(OMZ) in its dosage forms. The methods were based on the formation of charge-transfer complexes with both iodine and 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). The variables that aﬀected the reactions were carefully studied and optimized.
The formed complexes and the site of interaction were examined by UV/VIS, IR, and 1H-NMR techniques, and computational
molecular modeling. Under optimum conditions, the stoichiometry of the reactions between OMZ and the acceptors was found
to be 1 : 1. The order of the reactions and the speciﬁc rate constants were determined. The thermodynamics of the complexes
were computed and the mechanism of the reactions was postulated. The initial rate and ﬁxed time methods were utilized for the
determination of OMZ concentrations. The linear ranges for the proposed methods were 0.10–3.00 and 0.50–25.00μgmL
−1 with
thelowest LOD of0.03 and 0.14μgmL
−1 foriodineandDDQ, respectively. Analytical performanceofthemethods was statistically
validated; RSD was <1.25% for the precision and <1.95% for the accuracy. The proposed methods were successfully applied to the
analysis of OMZ in its dosage forms; the recovery was 98.91–100.32%± 0.94–1.84, and was found to be comparable with that of
reference method.
Copyright © 2009 Ashraf M. Mahmoud. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Omeprazole (OMZ), 5-methoxy-2-[[(4-methoxy-3,5-
dimethyl-2-pyridinyl)methyl]sulphinyl]-1H-benzimidazole,
is the ﬁrst member of the “proton pump inhibitors” that
are widely used for the prophylaxis and treatment of both
gastro-duodenal ulcers and symptomatic gastrooesophageal
reﬂux [1]. Also, it is highly eﬀective in the treatment of
Zollinger-Ellison syndrome [1, 2].
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The therapeutic importance of OMZ was behind the
development of many analytical methods for its determina-
tion in the pharmaceutical formulations and/or biological
samples. These methods include spectrophotometry [3–
13], electrochemical methods [14], HPLC [15–17], and
electrophoresis [18]. As compared to the electrochemical,
electrophoretic, and chromatographic methods, despite of
their higher sensitivity, the spectrophotometric methods are
more versatile and easy to apply. Direct UV spectrophotom-
etry has been proved to be inaccurate due to the matrix
interference [3]. Some reported visible spectrophotometric
methods [4], being based on the nonselective oxidation of
OMZ, may be also inﬂuenced by the excipients resulting
in inaccurate results. Therefore, accurate visible spectropho-
tometric methods are still required for the determination
of OMZ in quality control laboratories. The molecular
interactions between the electron donating pharmaceutical
compounds [19–23] and the electron acceptors are generally
associated with the formation of intensely colored charge-
transfer (CT) complexes [24]. Molecular CT complexes of
OMZ with both iodine as σ-acceptor and 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ) as π-acceptor have not
been studied yet. Therefore, both acceptors were selected
as analytical reagents in the present study. Kinetic spec-
trophotometric methods are becoming of great interest in2 International Journal of Analytical Chemistry
pharmaceuticalanalysis[25]astheyoﬀeredsomeadvantages
such as improved selectivity, avoiding the interference of
the colored and/or turbidity background of the samples,
and possible avoiding of the interference of the other active
compounds present in the commercial product if they are
resisting the reaction conditions established for the proposed
kinetic method. Therefore, the development of new kinetic
spectrophotometric methods for the determination of OMZ
initspharmaceuticalpreparationswastargeted.Studyingthe
kinetics, molecularities, thermodynamics, and association
constantsoftheCTcomplexesaswellastheirexaminationby
the spectroscopic techniques, and computational molecular
modeling usually provide information about the nature and
mechanism of the CT complex formation. An important
application for CT complexes with iodine is that the antithy-
roid activity could be expected for drugs whose association
constant with iodine exceeds 100l.mol−1. Above this value
the antithyroid activity is directly related to the value of
the association constant [26]. Therefore, it was important to
determinetheassociationconstantforOMZ-iodinecomplex
beside the method development.
2. Experimental
2.1. Apparatus. A Shimadzu model UV-1601 PC (Japan)
UV-VIS double beam spectrophotometer with matched 1-
cm quartz cells was used for recording the electronic absorp-
tion spectra and all measurements. 1H-NMRspectrawere
recorded in DMSO-d6 at 500MHz by Bruker-Ultra Shield
instrument (Bruker Co., USA). IR spectra were recorded
by FT-IR model Spectrum BX spectrometer (Perkin-Elmer,
USA).
2.2. Chemicals, Reagents, and Pharmaceutical Formulations.
OMZ (Hetero Drugs Ltd, Hyderabad, India) was used
as working standard. Iodine, resublimed (Riedel-De-Haen
AG, Germany), was 2mgmL−1 in 1,2-dichloroethane. The
solution was stable for at least 1 week at 4◦C. 2,3-Dichloro-
5,6-dicyano-1,4-benzoquinone (DDQ; Merck, Schuchardt,
Munich, Germany) solution was 4mgmL−1 in acetonitrile,
anditwasfreshlyprepareddaily.Gastrazolecapsules(Riyadh
Pharma, Saudi Arabia) and Losec tablets (Astra Zeneca,
Sweden) were labeled to contain 20mg OMZ per capsule or
tablet. All solvents and other chemicals used throughout this
s t u d yw e r eo fa n a l y t i c a lg r a d e .
2.3. Preparation of Standard and Sample Solutions
2.3.1. Preparation of Stock Standard Solution. Into a 100mL
calibrated ﬂask, 25mg of OMZ was accurately weighed,
dissolved in 20mL 1,2-dichloroethane (for the reaction with
iodine) or acetonitrile (for the reaction with DDQ), and
completed to volume with the same solvent to obtain a
s t o c ks o l u t i o no f0 . 2 5m gm L −1. These stock solutions were
further diluted with the respective solvents to obtain suitable
concentrations that lie in the linear range of each particular
assay method.
2.3.2. Preparation of Tablets or Capsules Solution. Twenty
tabletsorthecontentsoftwentycapsulesofeachformulation
were weighed and ﬁnely powdered. A quantity of the powder
equivalent to 25.00mg of OMZ was transferred into a
100mLcalibratedﬂask,dissolvedin20mLoftheappropriate
solvent, swirled and sonicated for 5 minutes. The ﬂask was
completed to volume with the same solvent, shaken well for
15 minutes, and ﬁltered. The ﬁrst portion of the ﬁltrate was
rejected and a measured volume of the ﬁltrate was diluted
quantitatively with the respective solvent to yield suitable
concentrations that lie in the linear range of each particular
assay method.
2.4. General Analytical Procedure
2.4.1. Initial Rate Method. Accurately measured aliquots of
OMZ solution (1.00–250.00μgmL −1) were transferred into
separate 10mL calibrated ﬂasks. One milliliter of iodine
(2.0mgmL−1) or DDQ (4.0mgmL−1)w a sa d d e d .T h e
solution was diluted to volume with 1,2-dichloroethane
(for iodine) or acetonitrile (for DDQ) and mixed well.
After mixing, the reaction mixture was monitored at room
temperature (25±2◦C) and the absorbance was recorded as
a function of time for 45 and 5 minutes at 362 or 418 for
iodine and DDQ, respectively, against reagent blank treated
similarly.
2.4.2. Fixed Time Method. One milliliter of the standard
or sample solution of OMZ (1.00–250.00μgmL −1)w a s
transferred into 10mL calibrated ﬂasks. One milliliter of
iodine (2.0mgmL−1) or DDQ (4.0mgmL−1)w a sa d d e d .
The solution was diluted to volume with the appropriate
solvent and mixed well. The reaction was allowed to proceed
f o r4 5a n d5m i n u t e sa tr o o mt e m p e r a t u r e( 2 5± 2◦C)
for iodine and DDQ, respectively. The absorbance of the
resultingsolutionswasmeasuredat362or418foriodineand
DDQ, respectively, against reagent blanks treated similarly.
2.5. Determination of the Stoichiometry of CT Reactions. Job’s
method of continuous variation [27] was employed. Master
equimolar solutions of OMZ and acceptors were prepared.
The concentrations of these solutions were 1 × 10
−5 M( f o r
iodine) in 1,2-dichloroethane and 1 × 10
−4 M (for DDQ) in
acetonitrile. Series of 10mL portions of the master solutions
of OMZ and the acceptor were made up in 10mL calibrated
ﬂasks comprising diﬀerent complementary proportions (0
: 10, 1 : 9, ..., 9 : 1, 10 : 0). The reactions were further
manipulated according to the general analytical procedures.
2.6. Preparation of the Complexes for IR and 1H-NMR
Measurements. A quantity of 0.1 mmol (∼35mg) of OMZ,
dissolved in the appropriate solvent, was added to an
equimolar amount of the acceptor in the same solvent in a
round-bottom ﬂask containing ∼30mL of the respective sol-
ventandstirredfor30minutes.Thesolventswereevaporated
underreducedpressure,andtheresultingresiduesweredried
over calcium chloride. The dried residues were used for both
IR and 1H-NMR measurements.International Journal of Analytical Chemistry 3
2.7. Association Constant and Free Energy Change. Series of
OMZ solutions (0.4×10−4–2.1×10−3 M) in the appropriate
solvent were prepared. In addition to these solutions,
iodine (3×10−3 M) and DDQ (3.6×10−3 M) solutions in
the appropriate solvent were equilibrated for 30 minutes
in a thermostatically controlled water bath at 25 ± 2◦C.
Five milliliters of each acceptor solution was mixed rapidly
with 5mL of OMZ solution in 10mL calibrated ﬂasks. The
absorbance of the solutions was measured immediately at
the corresponding maxima against reagent blanks treated
similarly.
2.8. Data Acquisition and Processing. The kinetic data
recorded for the proposed methods was transformed to the
Slide Write Plus software, version 5.011 (Advanced Graphics
Software,Inc.,CA,USA)forcurveﬁtting,regressionanalysis,
andstatisticalcalculations.Theinitialrate(V)ofthereaction
atdiﬀerentOMZconcentrationswasobtainedfromtheslope
of the tangent of the absorbance-time curve. The calibration
curve was constructed by plotting the logarithm of the initial
rate of the reaction (logV) versus the logarithm of the molar
concentration of OMZ (logC). Alternatively, the calibration
curve was constructed by plotting the absorbance measured
after a preselected ﬁxed time versus the concentration
of OMZ. The limits of detection (LOD) and limits of
quantitation(LOQ)weredetermined[28]usingtheformula:
LOD or LOQ = κSDa/b,w h e r eκ = 3.3f o rL O Da n d1 0f o r
LOQ, SDa is the standard deviation of the intercept, and b is
the slope.
3. Results andDiscussion
3.1. Spectral Characteristics of the Charge-Transfer Reactions
3.1.1. Reaction with σ-Acceptor. The violet-colored iodine
solution in 1,2-dichloroethane was changed into lemon yel-
low upon addition of OMZ. Examination of the absorption
spectrum of OMZ-iodine reaction product showed two
absorption maxima at 290 and 362nm; the ﬁrst peak is
about twofold more intense than the second (Figure 1).
The spectrum was found to be identical with that of tri-
iodide ion (I
−
3 ) in 1,2-dichloroethane. This identity in both
spectra proved that the color change and the appearance
of the new bands at 290 and 362nm were attributed to
the formation of OMZ-iodine CT complex with an ionized
structure OMZ-I+ ···I
−
3 . This OMZ complex should origi-
nate from an early intermediate outer complex as explained
by Scheme 1. Conﬁrming the CT nature of the reaction, the
violet-colored solution of iodine in 1,2-dichloroethane was
restored upon extracting OMZ from the complex by shaking
with aqueous mineral acids. Measurements were carried out
at 362 nm to avoid the interference from the native UV
absorption of OMZ at 290nm.
3.1.2. Reaction with DDQ. The interaction of OMZ with
DDQ in nonpolar solvents such as chloroform led to forma-
tion of colored CT complexes with low ε-values. However, in
acetonitrile OMZ-DDQ CT complex with high ε-values was
formed. This was attributed to complete electron transfer
from OMZ (D) to the acceptor moiety (A) accompanied
by the formation of intensely colored radical ions in polar
solvents [20], according to Scheme 2.
The high ionizing power of the acetonitrile is the driving
force for dissociation of the (D-A) complex to form the
intense colored radical ion. As shown in Figure 1,O M Z
has no considerable absorption band in the range of 400–
600 nm; however, the OMZ-DDQ CT complex has some
absorption bands characterized by 4 maxima at 346, 418,
548, and 588nm presumably due to the formation of a deep
red colored CT complex. The intensity of the maximum at
346nm is about two- to threefold the maximum at 418nm,
while the intensity of the maximum at 418nm is about 2.7-
fold the maxima at both 548 and 588nm. However, the
measurements at 346nm were irreproducible. Investigating
theelectronicspectrumofOMZ-DDQcomplexasafunction
of time in acetonitrile (Figure 2) revealed that the deep red-
colored solution (the intensity of the absorption bands at
the 400–600nm region) began to increase up to 5 minutes
and then leveled oﬀ for about 20 minutes and ﬁnally began
to disappear by increasing the time; however, the intensity
of the band at 346nm still is increasing up to more than
3 hours. Therefore, the measurements were carried out
at 418nm to obtain the higher sensitivity and to avoid
the irreproducibility of the measurements at 346nm. Such
spectral features were coincident with those observed for the
interaction of DDQ with other donors [21, 29, 30] and the
reported values of the radical anions of DDQ obtained by
the reduction method [31].
3.2. Optimization of Reaction Conditions
3.2.1. Eﬀect of Reagent Concentration. Studying the eﬀect
of the reagent concentrations on CT complex formation
indicated that 1mL of iodine (2.0mgmL−1) and DDQ
(4.0mgmL−1) working solutions were the optimum con-
centrations (i.e.,the ﬁnal concentrations of both reagents in
the measured solution become 0.2 and 0.4mgmL−1,r e s p . ) .
Higher concentrations of both reagents resulted in either
higher blank readings or decreased absorption intensity.
3.2.2.EﬀectofSolvent. Inordertoselectthemostappropriate
solvent, the reactions were carried out in diﬀerent solvents.
Small shifts in the position of the maximum absorption
peaks were observed, and the absorption intensities were
also inﬂuenced. 1,2-Dichloroethane was found to be an ideal
solvent in case of iodine, because it is favorable for the
formation of tri-iodide ion pair. Methylene chloride, chloro-
form, and carbon tetrachloride produced lower absorption
readings. Polar solvents were found to be unsuitable as
their blanks with iodine gave higher readings. However,
acetonitrile found to be an ideal solvent for DDQ, because
it oﬀered the maximum sensitivity. This was attributed to its
high dielectric constant that promotes the maximum yield
of radical anions, in addition to its high solvating power for
DDQ [32].4 International Journal of Analytical Chemistry
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Figure 1: Absorption spectra of OMZ (1), iodine, 0.20mgmL−1
in 1,2-dichloroethane (2), DDQ, 0.40mgmL−1 in acetonitrile (3),
OMZ-iodine complex in 1,2-dichloroethane at 25±2◦C( 4 ) ,a n d
OMZ-DDQ complex in acetonitrile at 25±2◦C (5). Concentrations
of OMZ were 30.00, 1.50, and 20.00μgmL
−1 for the absorption
spectra numbers (1), (4), and (5), respectively.
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Figure 2: Absorption spectra of OMZ-DDQ complex as a function
of time. The complex was generated by carrying out the reaction of
OMZ (20.00μgmL
−1) with DDQ (0.40μgmL
−1) in acetonitrile at
25 ±2◦C.
3.2.3. Eﬀect of Reaction Temperature. The optimum reaction
temperature for the investigated acceptors was determined
by following the color development at diﬀerent temperatures
(25, 40, 50, 60, and 70
◦C) using ﬁxed concentrations of
OMZ and the acceptors. The results indicated that room
temperature (25 ± 2◦C) was the ideal selection and higher
temperatures was found to decrease the absorption intensity.
3.2.4. Eﬀect of Time. Since the formation of the colored
CT products increases with time, it was deemed useful
to generate absorption-time curves (Figure 3)i no r d e rt o
determine the kinetics and thermodynamics of the investi-
gated CT reactions. This was performed by monitoring the
color development at room temperature. Complete color
development was attained after 45 and 5 minutes for iodine
and DDQ, respectively (Figure 3). The developed colors
remained stable at room temperature for at least further
40 and 20 minutes for iodine and DDQ, respectively. The
absorption intensity of OMZ-DDQ complex decreased dra-
maticallyafter20minutes.Theoptimumreactionconditions
f o rb o t ha c c e p t o r sw e r es u m m a r i z e di nTable 1.
3.3. Stoichiometry of the CT Reaction and the Proposed Site of
Interaction. J o b ’ sm e t h o do fc o n t i n u o u sv a r i a t i o n[ 27]w a s
used for determining the molar ratio of OMZ to each of the
two acceptors employed in this investigation. These ratios
were found to be 1:1 in both cases. This indicates that only
one site participated in the formation of the CT complex
and a univalent charged species is the possible site of the CT
process.
3.4. Spectroscopic Investigations for the Structure of
the CT Complexes
3.4.1. IR Studies. T h es t r u c t u r e so fO M Z - a c c e p t o r sc o m -
plexes were investigated by the IR spectroscopic technique.
The majority of IR measurements on the complexes have
been concerned with shifts in the vibration frequencies in
the donor, acceptor and/or both. The IR spectra of the
complexes showed diﬀerences compared with those of OMZ
and DDQ. These diﬀerences have been used to distinguish
between weak CT complexes and the products of electron
transfer or proton-transfer reactions [24]. As compared
to the stretching vibration frequencies of C≡Na n dC =O
bands in the IR spectrum of DDQ (2233, 1678cm−1), a
bathochromic shift was observed for these two bands in the
IR spectrum of the OMZ-DDQ complex (2227, 1654cm−1).
Such a bathochromic shift in these two bands could be
indicative for a higher charge density on their corresponding
functional groups [21]. These shifts were used as evidence
for the formation of CT complexes. The iodine acceptor
is IR inactive. Therefore, I compared the IR spectrum
of pure OMZ and its corresponding CT complexes with
the investigated acceptors. The results indicated that the
stretching vibrations of –NH-, C=N, C=C, and S=O bands
(3447, 1627, 1472, 1077cm−1, resp.) were bathochromic
shifted to lower frequencies (3434, 1627, 1432, 1026cm−1
and3422,1618,1452,1018cm−1 forOMZ-iodineandOMZ-
DDQ CT complexes, resp.).
3.4.2. 1H-NMR Studies. In the 1H-NMR spectra of the
complexes, generally, the protons of the donor are shifted
to a lower ﬁeld [19, 22, 23]. The 1H-NMR spectra of the
complexes of OMZ with diﬀerent acceptors were recorded
in d6-DMSO and compared with the spectrum of the free
drug. The 3-methyl, 5-methyl, 4-methoxy protons and the
aromatic proton in the position number 2 on the pyridine
ring (δ = 2.2, 2.2, 3.7 and 8.2ppm, resp.) were not aﬀected
indicating that pyridine ring might not contribute in the
electron donation. The protons of CH2 attached to theInternational Journal of Analytical Chemistry 5
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sulphur atom (δ = 4.7) were obviously shifted (Δδ =
0.2–0.5ppm) for both iodine and DDQ complexes. As well,
the 5-methoxy protons of benzimidzole ring (δ = 3.8ppm)
were obviously downﬁeld shifted (Δδ = 0.2–0.4ppm).
The aromatic protons of C4, C6, and C7 of benzimidazole
ring (Δδ =6.9, 7.1 and 7.5 ppm, resp.) were obviously
downﬁeld shifted (Δδ = 0.2–0.5ppm) for both iodine and
DDQ complexes. These results suggested that the electron-
donating site in OMZ is close to the aromatic protons
of benzimidazole, most probably the imidzole moiety of
OMZ. These data, together with above-mentioned IR data,
conﬁrmed the CT complex formation between OMZ and
both acceptors.
3.5. Molecular Modeling for the Charge-Transfer Complexes.
Molecular modeling for the CT complexes was carried
out using the MOPAC package in the CHEM 3D Ultra,
version 9.0 (ChemOﬃce software, CambridgeSoft Corpo-
ration, Cambridge, MA, USA) implemented with molec-
ular dynamics computations software (MM2). OMZ and
DDQ were energy-minimized alone and both together
to obtain the most energyminimized conformation of
OMZ CT complexes, the minimum energy of the complex
was 130.673kcalmol−1. Figure 4 shows the most energy-
minimized conformation of OMZ-DDQ complex. Further-
more,thetotalchargesonallnitrogenatomswerecalculated.
It was found that DDQ attacks OMZ at the area of
benzimidazole moiety. It is acceptable that certain electron
density was required for achievement of a successful electron
transfer [24]. Comparing the electron density on all nitrogen
atoms indicated that the benzimidazole nitrogen in the para-
position of OCH3-group has the highest density (−0.323)
as compared to the other benzimidazole nitrogen (−0.133)
and the pyridine nitrogen (−0.223) making it more likely to
donate its electrons to the acceptor.
3.6. Mechanism of the Studied CT Reactions. The spectro-
scopic results conﬁrmed that only one site is possible for
the formation of the CT complex. This site, taking into
account the molecular modeling for the CT complexes,
was postulated to be the benzimidazole moiety of OMZ.
Therefore, the plausible mechanism for the reaction of OMZ
with the investigated acceptors, taking DDQ as example, was
postulated as shown in Scheme 3.
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Figure 3 :T h ea b s o r b a n c e - t i m ec u r v ef o rt h er e a c t i o no fO M Z
at 25 ± 2◦C with (a) iodine (0.20mgmL−1) at 362nm; the
concentrations of OMZ were 1.45 × 10
−6 ( ), 2.90 × 10
−6 (),
4.35×10
−6 (), 5.80×10
−6 (), 7.25×10
−6 (◦), and 8.70×10
−6 M
(•), and (b) DDQ (0.40mgmL−1) at 418nm; the concentrations
of OMZ were 0.73 × 10
−5 (•), 1.45 × 10
−5 (◦), 2.90 × 10
−5 (),
5.80 ×10
−5 (), 8.70 ×10
−5 (), and 1.15 × 10
−4 M(  ).
Table 1: Optimum conditions for the charge-transfer reaction of
OMZ with both iodine and DDQ reagents.
Conditions Iodine method DDQ method
Acceptor conc. (mgmL−1)2 . 0 4 . 0
Solvent 1,2-Dichloroethane Acetonitrile
Reaction time (min) 45 5
Temperature (◦C) 25 ±22 5 ±2
λmax (nm) 362 418
3.7. Kinetic Studies
3.7.1. Order of the CT Complex Reactions. Under the
described optimum conditions, the absorbance-time curves6 International Journal of Analytical Chemistry
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Figure 4: The most energy-minimized conformation of OMZ-
DDQ charge-transfer complex.
for the reaction of OMZ with both iodine and DDQ were
generated (Figure 3). The initial rates of the reactions were
determined from the slope tangents of the absorption-time
curves. The order of the reaction with respect to the accep-
tors was determined by studying the reaction at diﬀerent
concentrations of the acceptors with ﬁxed concentration
of OMZ. The plot of the initial rate, dA/dt, against the
initial concentrations of the acceptors was linear indicating
that the initial order of the reaction with respect to the
acceptors was ≈1. As well, the order with respect to OMZ
was evaluated from the measurement of the rates of the CT
r e a c t i o n sa td i ﬀerent concentrations of OMZ using a ﬁxed
concentration of the acceptors, which was found to be ≈1,
too. However, under the optimized experimental conditions,
the concentration of OMZ was determined using relative
excessamountoftheacceptors.Therefore,pseudo-ﬁrstorder
conditions were obtained and the initial rates of the CT
reactions were found to obey the following equation [33]:
V =
ΔA
Δt
= K Cn,( 1 )
where V is the initial reaction rate, A is the absorbance,
t is the measuring time, K  is the pseudo-ﬁrst-order rate
constant, C is the molar concentration of OMZ, and n is
the order of the reaction. The logarithmic form of the above
equation is written as follows:
LogV = log
ΔA
Δt
= log K  +n logC. (2)
The order of the CT reactions was obtained from the
slopes (n)o fL o gV (at diﬀerent OMZ concentrations) versus
logC. The results obtained in Table 2 indicated that the
value of (n) was 0.87 and 0.99 (≈1) for iodine and DDQ
reactions, respectively. This proved that the order of the
studied CT reactions was ﬁrst order. The rate constants
(k) were calculated from the slopes of the plots of logAt
versustime,whereAt representtheabsorbanceoftheformed
complexes at time t. Table 2 indicates the values of the
speciﬁc rate constants of the CT reaction of OMZ with both
iodine and DDQ.
3.7.2. Activation Energy and Entropy of Activation of the
CT Complexes. The activation energy, the minimum kinetic
energyamoleculemustpossessinordertoundergoreaction,
can be determined from Arrhenius equation [34]:
V = k = Ae−Ea/RT,( 3 )
where k is the speciﬁc reaction rate, A is a constant known
as Arrhenius frequency factor, Ea is the activation energy,
T is the absolute temperature (273+◦C), and R is the gas
constant (1.987cal mol
−1 ◦C). The logarithmic form of the
above equation is written as follows:
Logk = log A −
Ea
2.303
RT. (4)International Journal of Analytical Chemistry 7
Table 2: Kinetic parameters obtained from Benesi-Hildebrand, Arrhenius, and ﬁrst-order linear plots of OMZ-acceptor CT complexes at
the speciﬁc λmax and reaction temperature.
Kinetic parameters Iodine method DDQ method
Correlation coeﬃcient (r) 0.9995 0.9999
Order of CT reaction (n) 0.87 0.99
Speciﬁc rate constant, s−1(k) ×104 5.45 56.18
Activation energy, kcalmol−1 (Ea)♠ −1.54 −1.95
Activation entropy change, kcalmol
−1 ◦C( ΔS◦) −69.96 −66.44
Molar absorptivity, l ·mol
−1 cm−1(ε) ×103 21.12 6.89
Standard free energy change, kcal mol
−1(ΔG◦) −5.91 −4.80
Association constant, l ·mol
−1(Kc) ×103 21.50 3.33
♠ :Negative sign of Ea indicates that the CT complex is decomposed by increasing temperature.
The activation energy of the kinetic reaction of OMZ
with the investigated acceptors was determined by studying
the CT reactions at diﬀerent temperatures: 25, 40, 60,
70, and 80◦C using ﬁxed concentrations of OMZ and the
acceptors. The absorption-time curves at these temperatures
were constructed to determine the initial rates, then plotting
logk versus 1/T to determine the slope (–Ea/2.303R)a n d
the intercept (logA) of the line. The obtained activation
energiesoftheinvestigatedcomplexeswereshowninTable 2.
The negative sign indicated that the CT complex formation
decreasedwithincreaseinthetemperature.Furthermore,the
change in the entropy of activation of the transition state of
the complexes was determined using the following equation
[34]:
A =

RT
Nh

· eS∗/R,( 5 )
where A is the Arrhenius frequency factor, T is the absolute
temperature, R is the gas constant, N is Avogadro’s number
(6.02214179 × 1023mol
−1), h is Planck’s constant (6.626 ×
10
−34J·s), and ΔS∗ is the change in the entropy of activation
(cal mol
−1 ◦C
−1). The obtained large negative entropies of
activation of the complexes (Table 2) support the formation
of more polar transition state in the polar solvent.
3.7.3. Association Constant and Standard Free Energy Change
of the CT Complexes. The association constant was evaluated
at the corresponding λmax for each OMZ–acceptor complex
using the Benesi-Hildebrand equation [35]:
[A◦]
AAD =
1
εAD +
1
KAD
c ·εAD ×
1
[D◦]
,( 6 )
where [A◦] is the concentration of the acceptor; [D◦]i s
the concentration of the donor; AAD is the absorbance of
the complex formed at the speciﬁc wavelength; εAD, the
molar absorptivity of the complex formed at the speciﬁc
wavelength; KAD
c is the association constant of the complex
(l mol−1). On plotting the values [A◦]/AAD versus l/[D◦],
straight lines were obtained, from which the association
constant, correlation coeﬃcient, and the molar absorptivity
of OMZ–acceptor complexes were calculated (Table 2).
Thestandardfreeenergychangeofthecomplexisrelated
to the association constant by the following equation [34]:
ΔG0 =− 2.303RT log Kc,( 7 )
whereΔG0 isthestandardfreeenergychangeofthecomplex;
R is the gas constant; T is the absolute temperature in Kelvin
(273+◦C); Kc is the association constant of OMZ-acceptor
complex (lmol−1). As compared to OMZ-iodine complex,
theassociationconstantofOMZ-DDQcomplexwasofmuch
l o w e rv a l u e( c o m m o nf e a t u r ef o rC Tc o m p l e x e sw i t hπ-
acceptors) due to the dissociation of the original donor-
acceptor complex to the radical anion [24]. However, the
observed high value for the association constant of the CT
complex with iodine suggests that the formed OMZ-iodine
complex is of a strong type [21]. Out of the many applica-
tions of CT complexes, the determination of the association
constant of the CT complexes of drugs with iodine could
determine the antithyroid activities of drugs [26]. Therefore,
the determination of the association constant of OMZ-I2
CT complexes (21.50 × 103lmol
−1) could determine the
potential iatrogenic antithyroid action of OMZ, and could
represent a further tool for the evaluation of drug safety.
This would be particularly valuable for prevention of thyroid
dysfunction in the neonate [26].
3.8. Validation of the Proposed Kinetic Methods
3.8.1. Linearity and Limits of Detection
(1) Initial Rate Method. Under the above described opti-
mum conditions, summarized in Table 1, the initial rates of
the CT reaction of OMZ with the acceptors would follow
a pseudo-ﬁrst-order kinetic and were found to obey the
following equation:
LogV = log
ΔA
Δt
= logK  +nlogC. (8)
Regression analysis using the method of least square was
performed to evaluate the slope, intercept, and correlation
coeﬃcient. The analytical parameters and results of regres-
sion analysis are given in Table 3. The limits of detection
(LOD) were calculated and found to be 0.24 and 0.41 ×
10
−6mol (0.08 and 0.14μgmL
−1), whereas the limits of8 International Journal of Analytical Chemistry
Table 3: Analytical parameters for the proposed kinetic initial rate methods for determination of OMZ.
Analytical parameters Iodine method DDQ method
Linear range (mol) 0.73–8.70 ×10
−6 1.45–72.4 ×10
−6
(0.25–3.00)
a (0.50–25.00)
Least square equation
(LogV = logK  +nlogC)
b
Intercept (logK ) ± SD 2.68 ±0.10 3.36 ±0.03
Slope (n) ±SD 0.87 ±0.02 0.99 ±0.01
Correlation coeﬃcient (r) 0.9990 0.9996
LOD
c (mol) 0.24 ×10
−6 (0.08) 0.41 ×10
−6 (0.14)
LOQ
c (mol) 0.73 ×10
−6 (0.25) 1.22 ×10
−6 (0.42)
a Figures in parenthesis are the quantities in μgm L −1.
bV is the reaction rate, K  is the conditional rate constant, n is the order of reaction, and C is the molar concentration of OMZ.
c To simplify the calculation of both LOD and LOQ, the simple nonlogarithmic equations [V = 0.001(±0.00015)+2093(±45)C]a n d[ V = 0.002(±0.00027)+
2391(±39)C] were used for both iodine and DDQ methods, respectively, where V is the reaction rate and C is the molar concentration of OMZ.
Table 4: Analytical parameters for the proposed ﬁxed time methods for determination of OMZ.
Method Time Range R Slope Intercept LOD LOQ
(min) (μgmL
−1)( b ) ± SD (a) ± SD (μgmL
−1)( μgmL
−1)
Iodine
5 1.50–12.00 0.9915 0.0751 ± 0.0049 0.0226 ± 0.0095 0.42 1.27
15 0.50–6.00 0.9955 0.1589 ± 0.0017 0.0060 ± 0.0073 0.15 0.46
25 0.40–5.00 0.9992 0.2198 ± 0.0044 0.0064 ± 0.0085 0.13 0.39
35 0.30–4.00 0.9995 0.2649 ± 0.0042 0.0323 ± 0.0061 0.08 0.23
45 0.10–3.00 0.9990 0.3069 ± 0.0067 0.0693 ± 0.0032 0.03 0.10
DDQ
1 10.00–120.00 0.9982 0.0065 ± 0.0002 0.0013 ± 0.0065 3.28 9.94
2 5.00–60.00 0.9992 0.0155 ± 0.0001 0.0097 ± 0.0028 0.59 1.80
3 3.00–40.00 0.9993 0.0249 ± 0.0006 0.0246 ± 0.0036 0.48 1.45
4 2.50–30.00 0.9992 0.0320 ± 0.0007 0.0305 ± 0.0017 0.18 0.53
5 0.60–25.00 0.9998 0.0366 ± 0.0004 0.0299 ± 0.0021 0.19 0.57
quantiﬁcation (LOQ) were 0.73 and 1.22 × 10
−6 mol (0.25
and 0.42μgmL
−1) for both iodine and DDQ methods,
respectively. These low values conﬁrmed the good sensitivity
of the initial rate method and consequently its capability
to determine OMZ in the linear range of 0.73–8.70 ×
10
−6mol (0.25–3.00μgmL
−1)a n d1 .45–72.4 × 10
−6mol
(0.5–25.00μgmL
−1) for both iodine and DDQ methods,
respectively.
(2) F i x e dT i m eM e t h o d .In this method, the absorbance
of the reaction solutions containing varying amounts of
OMZ was measured at a preselected ﬁxed time. Calibration
plots of absorbance versus the concentrations of OMZ
were established at ﬁxed periods of time for the reactions
(Table 4). The regression equations, correlation coeﬃcients,
and the limits of detection and quantiﬁcation are given in
Table 4. The lowest limits of detection and quantiﬁcation
were obtained with ﬁxed times of 45 minutes (for iodine)
and of 4 and 5 minutes (for DDQ) methods, respectively.
However, the ﬁxed times of 5 minutes (for iodine) and of
1 minute (for DDQ) methods showed wider dynamic range
for quantiﬁcation. Therefore, on the basis of wider dynamic
range and less time of analysis, the ﬁxed time of 5 and
1 minute for iodine and DDQ methods, respectively, was
recommended for the determination of OMZ by the ﬁxed
time method, if the sensitivity is not required (otherwise,
ﬁxed time of 45 and 5 minutes is better for both methods,
resp.).
Out of the many advantages of the kinetic spectropho-
tometric methods, one important advantage is that the long
reaction time could be overcome by applying the initial rate
method. This was the case in our proposed iodine method.
Therefore, the initial rate was preferred than the ﬁxed time
with respect to iodine method. However, the ﬁxed time is
preferred than the initial rate with respect to DDQ method
due to its short reaction time (5 minutes).
3.8.2. Precision and Accuracy. The precision and accuracy
were tested by applying the proposed methods using the
sameexperimental conditions asdescribedunderthegeneral
analytical procedure.
The precision of the proposed methods was determined
[36] at three concentration levels of OMZ (0.5, 1.5, and
3.0μgmL
−1 for iodine and 2.0, 10.0, and 20.0μgmL
−1 for
DDQ methods). This was performed by determination of
ﬁve replicate samples of each concentration by both the
initial rate and ﬁxed time methods. The results revealed that
the relative standard deviations (RSDs) of the values did not
exceed 1.25%.International Journal of Analytical Chemistry 9
Table 5: Evaluation of the accuracy of the proposed initial rate and ﬁxed time methods for determination of OMZ.
Method
Amount taken
(μgmL
−1) Recovery (%± RSD)
a
Initial rate method Fixed time method
Iodine
0.50 99.50 ± 1.95 100.40 ± 0.94
1.50 98.80 ± 1.08 99.80 ± 0.25
3.00 99.70 ± 1.55 98.50 ± 0.42
DDQ
2.00 98.60 ± 1.45 99.60 ± 1.84
10.00 98.90 ± 0.95 100.80 ± 0.75
20.00 100.30 ± 0.75 100.20 ± 1.25
a Recovery was calculated as the amount found/amount taken ×100. Values are mean ± RSD for ﬁve determinations.
Table 6: Determination of OMZ in presence of common excipients by the proposed ﬁxed time methods.
Ingredient Recovery ( %± SD)
a
Iodine method DDQ method
Starch (50)
b 99.26 ± 0.39 98.86 ± 0.66
Glucose (10) 99.42 ± 1.02 99.33 ± 1.53
Lactose (10) 100.49 ± 1.35 101.11 ± 1.45
Acacia (10) 101.02 ± 0.75 100.85 ± 0.64
MS
c (10) 99.31 ± 0.96 98.94 ± 0.75
Average ± SD 99.90 ± 0.80 99.82 ± 1.08
Pool SD 0.89 1.01
a Values are mean of three determinations.
b Figures in parenthesis are the amounts in mg added per 20mg of OMZ.
c MS=Magnesium stearate.
Theaccuracyoftheproposedmethodswasalsoevaluated
using the same (above-mentioned) concentrations of OMZ.
Table 5 showed the recovery results (98.50%–100.80%) with
RSD not more than 1.95%, proving the high accuracy of
the proposed methods. This high level of the precision and
accuracy indicated the suitability of the proposed methods
for the quality control analysis of OMZ in its pharmaceutical
preparations.
3.8.3. Speciﬁcity and Interference. The proposed kinetic
methods have the advantage of that all measurements are
performed in the visible region, away from the near UV
absorbing interfering substances that might be coextracted
from OMZ-containing dosage forms. The potential interfer-
ences from the excipients in the dosage forms were studied.
Samples were prepared by mixing known amount (20mg)
of OMZ with various amounts of the common excipients
such as starch, glucose, lactose, acacia, and magnesium
stearate. The results (Table 6) revealed that no interference
was observed from any of these excipients with the proposed
methods.
3.8.4. Ruggedness and Robustness. T h er u g g e d n e s sw a st e s t e d
by applying the proposed methods to the assay of OMZ
using the same operational conditions but using two diﬀer-
ent instruments at two diﬀerent laboratories and diﬀerent
elapsed time. Results obtained from lab-to-lab and day-to-
day variations were reproducible as RSD did not exceed 3%.
Robustness of the proposed procedures was examined by
evaluating the inﬂuence of small variation in the concentra-
tion of acceptor reagents (within ±5%) or in the reaction
temperature (25 ± 2◦C) on the analytical performance of
the proposed methods. In these experiments, one experi-
mental variable was changed, whereas the others were kept
unchanged, and the recovery percentage was calculated each
time. It was found that neither the temperature (23, 25, and
27
◦C were tested) nor the reagents concentration (1.9, 2.0,
and 2.1mgmL−1 of iodine and 3.8, 4.0, and 4.2mgmL−1 of
DDQ reagents were tested) signiﬁcantly aﬀected the results;
the recovery percentages were 98.64%–101.53%±0.92–1.67.
Thisprovidedanindicationforthereliabilityoftheproposed
methods during routine work.
3.9. Application of the Proposed Methods to the Analysis of
Pharmaceutical Preparations. Depending on the obtained
validation results, the proposed procedures were found to
be suitable for the routine quality control analysis of OMZ.
The proposed and the reference methods [12]w e r ea p p l i e d
to the determination of OMZ in its dosage forms. The
results obtained by the proposed methods were statistically
compared with those obtained by the reference method.
The recovery of the labeled amount was 98.91–100.32 ±
0.94%–1.84% (Table 7). The results of t-a n dF-tests revealed10 International Journal of Analytical Chemistry
Table 7: Determination of OMZ in its dosage forms by the proposed methods.
Dosage form
Label claim (%± SD)
a
Initial rate method Fixed-time method Reference
c method
Iodine DDQ Iodine DDQ
Gastrazole capsules 99.82 ± 1.65 98.91 ± 1.78 100.24 ± 1.84 99.20 ± 1.53 100.40 ± 1.34
t-value
b 0.63 1.51 0.2 1.32
F-value
b 1.52 1.76 1.89 1.30
Losec tablets 99.41 ± 1.24 99.70 ± 1.13 100.32 ± 0.94 99.93 ± 1.13 100.90 ± 1.18
t-value
b 1.96 1.64 0.14 0.64
F-value
b 1.10 1.09 0.63 0.92
a Values are mean of ﬁve determinations.
b The tabulated values of t and F at 95% conﬁdence limit are 2.78 and 6.39, respectively.
c Reference [12].
that no signiﬁcant diﬀerences were found between the
proposed and reference methods at 95% conﬁdence level
with respect to precision and accuracy. This proved the
applicability of the proposed methods for quality control
analysis of OMZ in its pharmaceutical preparations with
comparable analytical performance.
4. Conclusions
The present work utilized the colored CT complexes of
OMZ with both iodine and DDQ in the development of
new simple, rapid, sensitive, and accurate kinetic spec-
trophotometric methods for the analysis of OMZ in dosage
forms.Theobtained CTcomplexeshavebeen investigated by
UV-VIS spectrophotometry, IR, and 1H-NMR spectroscopic
techniques, and by computational molecular modeling. A
plausible mechanism for these CT reactions based on the
spectroscopic study was postulated. The proposed kinetic
methods are superior to the previously reported spectropho-
tometric methods in the term of sensitivity and improved
selectivity because the sensitivity of the proposed methods
(linear range was as low as 0.1μgmL
−1) is higher than
that of all reported spectrophotometric methods (the lowest
reported linear range was 0.2μgmL
−1) for determination of
OMZ [3–13]. Furthermore, the measurements of most of
thereportedspectrophotometricmethodswereperformedat
lower wavelengths (at258–320nm) whichmay be inﬂuenced
by the excipients of the dosage forms in contrast to the
proposed kinetic methods [5–10]. Moreover, some of the
reported colorimetric methods are time consuming [4, 9],
and others have been proved to be inaccurate due to matrix
interference [3].
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